| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | 6 | 39 | 312.3 | 357.3 |
| - | - | - | - | - | - | 0.3 | 0.3 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 138 |
| 222 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LO(L) | 1,066 | 66.1% | -10.06 | 1 | 0.1% |
| SPS(L) | 327 | 20.3% | 0.82 | 576 | 86.4% |
| Optic-unspecified(L) | 133 | 8.2% | -inf | 0 | 0.0% |
| IB | 31 | 1.9% | 1.42 | 83 | 12.4% |
| PLP(L) | 47 | 2.9% | -3.23 | 5 | 0.7% |
| CentralBrain-unspecified | 9 | 0.6% | -2.17 | 2 | 0.3% |
| upstream partner | # | NT | conns LoVP33 | % In | CV |
|---|---|---|---|---|---|
| LoVP33 (L) | 3 | GABA | 86.7 | 16.9% | 0.1 |
| Tm38 (L) | 15 | ACh | 50.7 | 9.9% | 0.7 |
| Li36 (L) | 1 | Glu | 45 | 8.8% | 0.0 |
| TmY17 (L) | 19 | ACh | 34.3 | 6.7% | 0.6 |
| Tm37 (L) | 25 | Glu | 34 | 6.6% | 0.7 |
| Tm31 (L) | 7 | GABA | 26.3 | 5.1% | 0.3 |
| Li23 (L) | 10 | ACh | 19.7 | 3.8% | 0.9 |
| TmY20 (L) | 13 | ACh | 18 | 3.5% | 0.6 |
| LC10e (L) | 7 | ACh | 17 | 3.3% | 0.5 |
| LC10d (L) | 7 | ACh | 16.7 | 3.3% | 0.7 |
| Li14 (L) | 10 | Glu | 12 | 2.3% | 0.7 |
| Tm16 (L) | 15 | ACh | 10.7 | 2.1% | 0.7 |
| LoVC19 (L) | 2 | ACh | 9.3 | 1.8% | 0.1 |
| LoVP29 (L) | 1 | GABA | 8.3 | 1.6% | 0.0 |
| TmY10 (L) | 9 | ACh | 8 | 1.6% | 0.9 |
| LC36 (L) | 6 | ACh | 7.3 | 1.4% | 1.1 |
| PS265 (L) | 1 | ACh | 7 | 1.4% | 0.0 |
| TmY9a (L) | 8 | ACh | 5.7 | 1.1% | 0.5 |
| Li22 (L) | 3 | GABA | 4.3 | 0.8% | 0.7 |
| Tm34 (L) | 4 | Glu | 4.3 | 0.8% | 0.5 |
| LC14b (R) | 1 | ACh | 4 | 0.8% | 0.0 |
| TmY5a (L) | 7 | Glu | 4 | 0.8% | 0.6 |
| MeLo1 (L) | 3 | ACh | 3.7 | 0.7% | 0.6 |
| LHPV2i2_a (L) | 1 | ACh | 3.3 | 0.7% | 0.0 |
| LHPV2i1 (L) | 1 | ACh | 3.3 | 0.7% | 0.0 |
| LC28 (L) | 2 | ACh | 3 | 0.6% | 0.1 |
| LoVP14 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LoVP86 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| Li20 (L) | 3 | Glu | 3 | 0.6% | 0.9 |
| Y3 (L) | 2 | ACh | 3 | 0.6% | 0.3 |
| LC10b (L) | 3 | ACh | 2.7 | 0.5% | 0.6 |
| LC13 (L) | 8 | ACh | 2.7 | 0.5% | 0.0 |
| IB025 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LC22 (L) | 2 | ACh | 1.7 | 0.3% | 0.6 |
| LC10c-1 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| LoVC29 (R) | 2 | Glu | 1.3 | 0.3% | 0.5 |
| Tm36 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| TmY9b (L) | 2 | ACh | 1.3 | 0.3% | 0.5 |
| LoVCLo3 (R) | 1 | OA | 1.3 | 0.3% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1.3 | 0.3% | 0.0 |
| AVLP469 (L) | 1 | GABA | 1.3 | 0.3% | 0.0 |
| IB061 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| LT69 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| OLVC7 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| LC40 (L) | 2 | ACh | 1 | 0.2% | 0.3 |
| PLP106 (L) | 2 | ACh | 1 | 0.2% | 0.3 |
| LoVP46 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVCLo2 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| LoVP101 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LT63 (L) | 2 | ACh | 1 | 0.2% | 0.3 |
| aMe5 (L) | 3 | ACh | 1 | 0.2% | 0.0 |
| LC21 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| PLP162 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LPC2 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LC9 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LLPC3 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LT70 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| Tm33 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| Li35 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| MeVP55 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| LoVP16 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| LT52 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| MeVC21 (L) | 2 | Glu | 0.7 | 0.1% | 0.0 |
| LoVC22 (R) | 2 | DA | 0.7 | 0.1% | 0.0 |
| LoVC1 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| PS187 (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| PLP016 (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| LoVP106 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CL269 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeLo7 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LC20a (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LC10a (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LC46b (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| TmY4 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| ANXXX030 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| PLP231 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| Li33 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP54 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PS300 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| AVLP593 (L) | 1 | unc | 0.3 | 0.1% | 0.0 |
| OA-ASM1 (L) | 1 | OA | 0.3 | 0.1% | 0.0 |
| LT36 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| Li21 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LT77 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LoVP_unclear (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| IB092 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LOLP1 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| LO_unclear (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LC29 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LoVC26 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LT65 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CL128_a (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| LC4 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP55 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| PS312 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LC11 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LT58 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CRE106 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CL111 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LoVC18 (L) | 1 | DA | 0.3 | 0.1% | 0.0 |
| OLVC5 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP7 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LoVP47 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LPT100 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP5 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| P1_9b (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| IB101 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| Li39 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| mALD1 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| downstream partner | # | NT | conns LoVP33 | % Out | CV |
|---|---|---|---|---|---|
| LoVP33 (L) | 3 | GABA | 86.7 | 17.4% | 0.1 |
| PS172 (L) | 1 | Glu | 65.3 | 13.1% | 0.0 |
| PS265 (L) | 1 | ACh | 54.7 | 11.0% | 0.0 |
| IB061 (L) | 1 | ACh | 51.7 | 10.4% | 0.0 |
| CL029_a (L) | 1 | Glu | 23.3 | 4.7% | 0.0 |
| MeVP57 (R) | 1 | Glu | 20.7 | 4.1% | 0.0 |
| LoVP29 (L) | 1 | GABA | 20.3 | 4.1% | 0.0 |
| PS311 (L) | 1 | ACh | 16.3 | 3.3% | 0.0 |
| DNpe009 (L) | 2 | ACh | 15.7 | 3.1% | 1.0 |
| PS285 (L) | 3 | Glu | 13.3 | 2.7% | 1.3 |
| IB069 (L) | 1 | ACh | 11 | 2.2% | 0.0 |
| PS339 (L) | 1 | Glu | 10.3 | 2.1% | 0.0 |
| CB3977 (L) | 1 | ACh | 8.7 | 1.7% | 0.0 |
| DNae008 (L) | 1 | ACh | 8.7 | 1.7% | 0.0 |
| DNp16_a (L) | 1 | ACh | 8.3 | 1.7% | 0.0 |
| VES074 (L) | 1 | ACh | 7 | 1.4% | 0.0 |
| VES204m (L) | 2 | ACh | 7 | 1.4% | 0.1 |
| PS187 (L) | 1 | Glu | 6 | 1.2% | 0.0 |
| MeVP55 (R) | 1 | Glu | 4 | 0.8% | 0.0 |
| DNbe004 (L) | 1 | Glu | 3.7 | 0.7% | 0.0 |
| AOTU023 (L) | 1 | ACh | 3.7 | 0.7% | 0.0 |
| MeVPMe5 (R) | 2 | Glu | 3 | 0.6% | 0.8 |
| CL072 (L) | 1 | ACh | 2.7 | 0.5% | 0.0 |
| DNp70 (R) | 1 | ACh | 2.7 | 0.5% | 0.0 |
| AOTU023 (R) | 1 | ACh | 2.3 | 0.5% | 0.0 |
| LoVP86 (R) | 1 | ACh | 2.3 | 0.5% | 0.0 |
| PS186 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| DNd05 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| DNpe042 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| MeVP6 (L) | 1 | Glu | 1.7 | 0.3% | 0.0 |
| DNpe022 (L) | 1 | ACh | 1.7 | 0.3% | 0.0 |
| PS338 (L) | 1 | Glu | 1.3 | 0.3% | 0.0 |
| DNpe017 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| PS314 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| PS242 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| DNb06 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| CL067 (L) | 1 | ACh | 1.3 | 0.3% | 0.0 |
| MeVP61 (L) | 1 | Glu | 1.3 | 0.3% | 0.0 |
| DNp16_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| DNp70 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PS300 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PS201 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVC22 (R) | 2 | DA | 1 | 0.2% | 0.3 |
| CB1834 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| MeVP55 (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| PS280 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| IB101 (R) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| PS183 (L) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| PS174 (L) | 1 | Glu | 0.7 | 0.1% | 0.0 |
| PS263 (L) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| LoVC22 (L) | 2 | DA | 0.7 | 0.1% | 0.0 |
| CL111 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| AVLP710m (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| CL269 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LAL184 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CB1554 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| SAD043 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| AVLP464 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| IB076 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| LPT114 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| MeVP54 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CL111 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| IB060 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| PS051 (R) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| IB092 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CB1641 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| LT70 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| IB121 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| Lat5 (L) | 1 | unc | 0.3 | 0.1% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| VES045 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| PS307 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CB2674 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| WED098 (L) | 1 | Glu | 0.3 | 0.1% | 0.0 |
| CB3220 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| VES102 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| IB051 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| IB051 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| MeVP59 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CL333 (L) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| CB0671 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |
| PVLP130 (L) | 1 | GABA | 0.3 | 0.1% | 0.0 |